Construction and in vitro characterization of a chimeric simian and human immunodeficiency virus with the RANTES gene

Microbes and Infection

Volumn 8, Issue 1, 2006, Pages 105-113

  Shimizu, Yuya ^a   Okoba, Masashi ^a   Yamazaki, Nanase ^a   Goto, Yoshitaka ^a   Miura, Tomoyuki ^b   Hayami, Masanori ^b   Hoshino, Hiroo ^c   Haga, Takeshi ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

AIDS; HIV 1; RANTES; SHIV

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR5; PROTEIN ANTIBODY; RANTES; RANTES ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CHIMERA; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; ENVELOPE GENE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACACA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; VIRUS CHARACTERIZATION; VIRUS REPLICATION;

ANIMALS; CELL LINE; DOWN-REGULATION; GENETIC ENGINEERING; HIV; HUMANS; MACACA FASCICULARIS; RANTES; RECEPTORS, CCR5; RECOMBINATION, GENETIC; SIMIAN IMMUNODEFICIENCY VIRUS; TIME FACTORS; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 31344460340     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.06.017     Document Type: Article

References (41)

1. T. Kuwata, T. Igarashi, E. Ido, M. Jin, A. Mizuno, J. Chen, and M. Hayami Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication J. Gen. Virol. 76 Pt. 9 1995 2181 2191
2. Y. Enose, M. Ui, A. Miyake, H. Suzuki, H. Uesaka, T. Kuwata, J. Kunisawa, H. Kiyono, H. Takahashi, T. Miura, and M. Hayami Protection by intranasal immunization of a nef-deleted, nonpathogenic SHIV against intravaginal challenge with a heterologous pathogenic SHIV Virology 298 2002 306 316
3. M. Ui, T. Kuwata, T. Igarashi, K. Ibuki, Y. Miyazaki, I.L. Kozyrev, Y. Enose, T. Shimada, H. Uesaka, H. Yamamoto, T. Miura, and M. Hayami Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs Virology 265 1999 252 263
4. T.W. Baba, V. Liska, A.H. Khimani, N.B. Ray, P.J. Dailey, D. Penninck, R. Bronson, M.F. Greene, H.M. McClure, L.N. Martin, and R.M. Ruprecht Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques Nat. Med. 5 1999 194 203
5. B.R. Gundlach, M.G. Lewis, S. Sopper, T. Schnell, J. Sodroski, C. Stahl-Hennig, and K. Uberla Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain J. Virol. 74 2000 3537 3542
6. R.P. Johnson, and R.C. Desrosiers Protective immunity induced by live attenuated simian immunodeficiency virus Curr. Opin. Immunol. 10 1998 436 443
7. L. Giavedoni, S. Ahmad, L. Jones, and T. Yilma Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques J. Virol. 71 1997 866 872
8. C. Stahl-Hennig, B.R. Gundlach, U. Dittmer, P. ten Haaft, J. Heeney, W. Zou, D. Emilie, S. Sopper, and K. Uberla Replication, immunogenicity, and protective properties of live-attenuated simian immunodeficiency viruses expressing interleukin-4 or interferon-gamma Virology 305 2003 473 485
9. F. Sallusto, A. Lanzavecchia, and C.R. Mackay Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses Immunol. Today 19 1998 568 574
10. A. Frauenschuh, A.L. DeVico, S.P. Lim, R.C. Gallo, and A. Garzino-Demo Differential polarization of immune responses by co-administration of antigens with chemokines Vaccine 23 2004 546 554
11. J.J. Kim, L.K. Nottingham, J.I. Sin, A. Tsai, L. Morrison, J. Oh, K. Dang, Y. Hu, K. Kazahaya, M. Bennett, T. Dentchev, D.M. Wilson, A.A. Chalian, J.D. Boyer, M.G. Agadjanyan, and D.B. Weiner CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines J. Clin. Invest. 102 1998 1112 1124
12. P.M. Waterman, M. Kitabwalla, G.S. Hatfield, P.S. Evans, Y. Lu, I. Tikhonov, J.L. Bryant, and C.D. Pauza Effects of virus burden and chemokine expression on immunity to SHIV in nonhuman primates Viral Immunol. 17 2004 545 557
13. K.Q. Xin, Y. Lu, K. Hamajima, J. Fukushima, J. Yang, K. Inamura, and K. Okuda Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity Clin. Immunol. 92 1999 90 96
14. R.K. Ahmed, C. Nilsson, Y. Wang, T. Lehner, G. Biberfeld, and R. Thorstensson Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge J. Gen. Virol. 80 Pt. 7 1999 1569 1574
15. M.C. Gauduin, R.L. Glickman, S. Ahmad, T. Yilma, and R.P. Johnson Immunization with live attenuated simian immunodeficiency virus induces strong type 1T helper responses and beta-chemokine production Proc. Natl. Acad. Sci. USA 96 1999 14031 14036 (B)
16. J.L. Heeney, V.J. Teeuwsen, M. van Gils, W.M. Bogers, C. De Giuli Morghen, A. Radaelli, S. Barnett, B. Morein, L. Akerblom, Y. Wang, T. Lehner, and D. Davis Beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques Proc. Natl. Acad. Sci. USA 95 1998 10803 10808
17. F. Cocchi, A.L. DeVico, A. Garzino-Demo, S.K. Arya, R.C. Gallo, and P. Lusso Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells Science 270 1995 1811 1815
18. G. Alkhatib, C. Combadiere, C.C. Broder, Y. Feng, P.E. Kennedy, P.M. Murphy, and E.A. Berger CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 Science 272 1996 1955 1958
19. T. Kuwata, T. Miura, T. Haga, I. Kozyrev, and M. Hayami Construction of chimeric simian and human immunodeficiency viruses that produce interleukin 12 AIDS Res. Hum. Retroviruses 16 2000 465 470
20. T. Haga, M. Okoba, N. Yamazaki, S. Kumabe, Y. Shimizu, Y. Goto, T. Kuwata, I.L. Kozyrev, M. Hayami, and T. Miura Characterization of vpr vector constructed from chimeric simian and human immunodeficiency virus J. Vet. Med. Sci. 65 2003 633 636
21. M. Kozak Comparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles Microbiol. Rev. 47 1983 1 45
22. T. Haga, Y. Shimizu, M. Okoba, S. Kumabe, Y. Goto, T. Shinjo, H. Ichimura, T. Kuwata, M. Hayami, and T. Miura Construction and in vitro properties of chimeric simian and human immunodeficiency virus with the human TNF-alpha gene Microbiol. Immunol. 46 2002 849 855
23. P.R. Clapham, R.A. Weiss, A.G. Dalgleish, M. Exley, D. Whitby, and N. Hogg Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester Virology 158 1987 44 51
24. H. Akari, K. Mori, K. Terao, I. Otani, M. Fukasawa, R. Mukai, and Y. Yoshikawa In vitro immortalization of Old World monkey T lymphocytes with Herpesvirus saimiri: its susceptibility to infection with simian immunodeficiency viruses Virology 218 1996 382 388
25. P. Lusso, F. Cocchi, C. Balotta, P.D. Markham, A. Louie, P. Farci, R. Pal, R.C. Gallo, and M.S. Reitz Jr. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1 J. Virol. 69 1995 3712 3720
26. Y. Soda, N. Shimizu, A. Jinno, H.Y. Liu, K. Kanbe, T. Kitamura, and H. Hoshino Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line Biochem. Biophys. Res. Commun. 258 1999 313 321
27. L.J. Reed, and H. Muench A simple method of estimating fifty per cent endpoints Am. J. Hyg. 27 1938 493 497
28. S. Gartner, P. Markovits, D.M. Markovitz, M.H. Kaplan, R.C. Gallo, and M. Popovic The role of mononuclear phagocytes in HTLV-III/LAV infection Science 233 1986 215 219
29. M. Mack, B. Luckow, P.J. Nelson, J. Cihak, G. Simmons, P.R. Clapham, N. Signoret, M. Marsh, M. Stangassinger, F. Borlat, T.N. Wells, D. Schlondorff, and A.E. Proudfoot Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity J. Exp. Med. 187 1998 1215 1224
30. K. Suryanarayana, T.A. Wiltrout, G.M. Vasquez, V.M. Hirsch, and J.D. Lifson Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction AIDS Res. Hum. Retroviruses 14 1998 183 189
31. T. Haga, T. Kuwata, I. Kozyrev, T.B. Kwofie, M. Hayami, and T. Miura Construction of an SIV/HIV type 1 chimeric virus with the human interleukin 6 gene and its production of interleukin 6 in monkey and human cells AIDS Res. Hum. Retroviruses 16 2000 577 582
32. N. Signoret, A. Pelchen-Matthews, M. Mack, A.E. Proudfoot, and M. Marsh Endocytosis and recycling of the HIV coreceptor CCR5 J. Cell Biol. 151 2000 1281 1294
33. L. Wu, G. LaRosa, N. Kassam, C.J. Gordon, H. Heath, N. Ruffing, H. Chen, J. Humblias, M. Samson, M. Parmentier, J.P. Moore, and C.R. Mackay Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding J. Exp. Med. 186 1997 1373 1381
34. T. Lehner, Y. Wang, M. Cranage, L.A. Bergmeier, E. Mitchell, L. Tao, G. Hall, M. Dennis, N. Cook, R. Brookes, L. Klavinskis, I. Jones, C. Doyle, and R. Ward Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques Nat. Med. 2 1996 767 775
35. L.D. Giavedoni, and T. Yilma Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon J. Virol. 70 1996 2247 2251
36. B.R. Gundlach, H. Linhart, U. Dittmer, S. Sopper, S. Reiprich, D. Fuchs, B. Fleckenstein, G. Hunsmann, C. Stahl-Hennig, and K. Uberla Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2 J. Virol. 71 1997 2225 2232
37. M. Robert-Guroff, M. Popovic, S. Gartner, P. Markham, R.C. Gallo, and M.S. Reitz Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages J. Virol. 64 1990 3391 3398
38. A. Kinter, A. Catanzaro, J. Monaco, M. Ruiz, J. Justement, S. Moir, J. Arthos, A. Oliva, L. Ehler, S. Mizell, R. Jackson, M. Ostrowski, J. Hoxie, R. Offord, and A.S. Fauci CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction Proc. Natl. Acad. Sci. USA 95 1998 11880 11885
39. T.J. Schall, J. Jongstra, B.J. Dyer, J. Jorgensen, C. Clayberger, M.M. Davis, and A.M. Krensky A human T cell-specific molecule is a member of a new gene family J. Immunol. 141 1988 1018 1025
40. L. Wagner, O.O. Yang, E.A. Garcia-Zepeda, Y. Ge, S.A. Kalams, B.D. Walker, M.S. Pasternack, and A.D. Luster Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans Nature 391 1998 908 911
41. T. Oravecz, M. Pall, J. Wang, G. Roderiquez, M. Ditto, and M.A. Norcross Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans J. Immunol. 159 1997 4587 4592